Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
0.3000
-0.1120 (-27.18%)
At close: Apr 2, 2025, 4:00 PM
0.2598
-0.0402 (-13.40%)
After-hours: Apr 2, 2025, 7:45 PM EDT

Processa Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
238187770
Upgrade
Market Cap Growth
-64.97%-64.97%-53.15%-77.16%10.52%-29.44%
Upgrade
Enterprise Value
10295871
Upgrade
Last Close Price
0.410.886.6922.0098.00131.90
Upgrade
PB Ratio
0.901.701.652.363.023.04
Upgrade
P/TBV Ratio
1.701.701.652.364.424.95
Upgrade
Debt / Equity Ratio
0.040.040.030.030.000.01
Upgrade
Quick Ratio
0.780.786.446.5117.0612.82
Upgrade
Current Ratio
1.221.227.718.4018.8713.27
Upgrade
Return on Equity (ROE)
-354.51%-354.51%-178.52%-166.43%-47.20%-93.14%
Upgrade
Return on Assets (ROA)
-167.08%-167.08%-99.41%-72.17%-27.98%-22.29%
Upgrade
Return on Capital (ROIC)
-218.02%-218.02%-111.54%-76.12%-29.61%-24.90%
Upgrade
Earnings Yield
-683.56%-410.42%-134.94%-155.91%-14.84%-20.69%
Upgrade
FCF Yield
-648.85%-389.57%-97.87%-54.61%-11.32%-4.51%
Upgrade
Buyback Yield / Dilution
-133.30%-133.30%-62.83%-5.16%-104.27%-35.72%
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q